Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Polypharmacy and medication management in geriatric oncology

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.12.19
Views: 291

Dr Ginah Nightingale - Thomas Jefferson University, Philadelphia, USA

Dr Gina Nightingale speaks to ecancer at the SIOG 2019 meeting about her involvement with the Association of Community Cancer Centers (ACCC).

Firstly, Dr Nightingale outlines why polypharmacy management is a problem in older patients, and why it is a common scenario leading to adverse events.

She describes the model used at her cancer centre, and outlines why she thinks it is a good way forward, where patients using multiple medications can be reviewed and potentially interventions can be made to reduce the number of drugs being used.

This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.

Related videos

follow us

WIN 2020

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation